Ascendis Pharma A/S (ASND)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Show:
Annual
Cash flow
Currency in EUR. All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-501,568
-481,447
-583,194
-383,577
-418,955
-
Depreciation & amortisation
18,842
18,911
17,958
15,391
9,448
-
Deferred income taxes
8,514
7,303
5,377
-367
-219
-
Stock-based compensation
70,253
66,660
64,180
66,830
53,170
-
Change in working capital
-127,626
-99,786
-12,472
-47,721
-964
-
Inventory
-81,830
-78,258
-55,268
-75,405
0
-
Other working capital
-423,455
-469,803
-510,188
-441,883
-293,100
-
Other non-cash items
82,579
-2,146
-4,241
-58,172
75,531
-
Net cash provided by operating activities
-421,899
-467,361
-495,699
-417,649
-271,548
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,556
-2,442
-14,489
-24,234
-21,552
-
Acquisitions, net
-
0
0
-10,187
0
-
Purchases of investments
-
0
-213,842
-226,038
-537,752
-
Sales/maturities of investments
84,488
288,865
280,528
149,880
263,051
-
Net cash used for investing activities
82,983
286,474
61,732
-110,579
-291,199
-
Cash flows from financing activities
Debt repayment
-10,656
-10,438
-6,356
-6,429
-4,774
-
Common stock issued
-
0
0
367,884
580,542
-
Common stock repurchased
-
0
-105,305
-21,605
0
-
Other financing activities
-
-1,812
-
-21,605
-31,373
-31,701
Net cash used provided by (used for) financing activities
153,417
134,292
396,773
351,387
602,650
-
Net change in cash
-185,499
-46,595
-37,194
-176,841
39,903
-
Cash at beginning of period
501,281
444,767
446,267
584,517
598,106
-
Cash at end of period
315,782
392,164
444,767
446,267
584,517
-
Free cash flow
Operating cash flow
-421,899
-467,361
-495,699
-417,649
-271,548
-
Capital expenditure
-1,556
-2,442
-14,489
-24,234
-21,552
-
Free cash flow
-423,455
-469,803
-510,188
-441,883
-293,100
-
© 2024 Yahoo. All rights reserved.